David J. Taylor
Suspicious Timing Detected
5 flagsRep. David J. Taylor bought $1,001 - $15,000 in $V (Visa Inc.) on 2026-02-09 — 2 days before HR3682 ("Financial Stability Oversight Council Improvement Act of 2025") was introduced, a bill with bullish sentiment for the financial sector.
Rep. David J. Taylor bought $1,001 - $15,000 in $AMZN (Amazon.com, Inc. - Common Stock) on 2026-02-09 — 37 days before S3303 ("LINC VA Act") was introduced, a bill with bullish sentiment for companies involved in veteran services platforms.
Rep. David J. Taylor bought $1,001 - $15,000 in $AMZN (Amazon.com, Inc. - Common Stock) on 2026-02-09 — 38 days before S3952 ("Future of Artificial Intelligence Innovation Act of 2026") was introduced, a bill with bullish sentiment for AI development.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Date |
|---|---|---|---|---|
| BUY | $AMZN | Amazon.com, Inc. - Common Stock | $1K-$15K | Feb 9, 2026 |
| BUY | $MSFT | Microsoft Corporation - Common Stock | $1K-$15K | Feb 9, 2026 |
| BUY | $PG | Procter & Gamble Company | $1K-$15K | Feb 9, 2026 |
| BUY | $PGR | Progressive Corporation | $1K-$15K | Feb 10, 2026 |
| BUY | $CRM | Salesforce, Inc. Common Stock | $1K-$15K | Feb 9, 2026 |
| BUY | $V | Visa Inc. | $1K-$15K | Feb 9, 2026 |
| SELL | $LLY | Eli Lilly and Company Common Stock | $1K-$15K | Feb 9, 2026 |
| SELL | $PH | Parker-Hannifin Corporation Common Stock | $1K-$15K | Feb 9, 2026 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
Financial Stability Oversight Council Improvement Act of 2025
HR 3682 (Financial Stability Oversight Council Improvement Act) passed the House 2026-02-09 and now has an identical Senate companion bill (S3578). The bill requires FSOC to exhaust alternative actions before designating nonbank financial firms as systemically important, reducing regulatory risk for large nonbank financial companies. This is structurally bullish for Berkshire Hathaway, Blackstone, PayPal, Visa, and Mastercard by lowering odds of future Fed supervision and associated capital requirements.
MEDLINE INDUSTRIES, LP: $77.6M Department of Veterans Affairs Contract
Medline Industries, a private company, secured a $77.6 million contract from the Department of Veterans Affairs for medical-surgical supplies. This contract highlights ongoing government demand for healthcare provisions, indirectly benefiting publicly traded medical supply distributors and healthcare service providers.
To prohibit a person from making a misleading recycled content claim in advertising, marketing, selling, or offering for sale a product to a consumer, and for other purposes.
HR7502 proposes a federal standard prohibiting misleading recycled content claims in consumer product marketing. The bill is in early committee stage with 9 cosponsors and limited legislative momentum. For $PG, $KO, $PEP, $KMB, and $CL, the bill imposes added compliance costs with no revenue offset — structurally bearish but low probability of passage in current form.
Pensions for All Act
HR7556 mandates employer-provided retirement plans, structurally bullish for asset managers like BlackRock ($BLK) by expanding AUM. However, the bill is in early stage, referred to three committees in February 2026, with no clear path to passage. Market impact is limited to long-term structural narrative; no near-term catalyst.
Bringing the Discount Window into the 21st Century Act
HR3390 is a procedural bill requiring a Federal Reserve review of discount window operations. It authorizes no funding, mandates no contracts, and has zero material linkage to any publicly traded company's revenue or costs. No actionable market impact exists for retail investors.
PROTECT Taiwan Act
HR1531 (PROTECT Taiwan Act) is an early-stage bill that authorizes no spending and creates only contingent geopolitical risk for major U.S. banks with Asia exposure. Real market data shows C, BAC, and MS are all trading near their 52-week highs with positive momentum over the last 30 days. No immediate market impact; the bill remains in committee.
Most Favored Patient Act of 2026
HR7837, the Most Favored Patient Act of 2026, is a bearish catalyst for major pharmaceutical companies with high Medicare exposure. The bill proposes linking US Medicare drug prices to the lowest global price, directly threatening the US pricing premium that supports current industry margins. The bill is in early legislative stages but represents a credible structural threat to pharmaceutical pricing power.
Enhanced Cybersecurity for SNAP Act of 2026
The Enhanced Cybersecurity for SNAP Act mandates chip-enabled and mobile-friendly EBT cards, creating a forced contract upgrade cycle for payment processors FIS and GPN. The bill is early-stage with no appropriated funding, but the mandate structure ensures state-level spending on compliance. Current market prices for FIS at $46.25 and GPN at $71.42 offer potential entry points ahead of legislative momentum, with both stocks trading well below their 52-week highs.
Small Business Artificial Intelligence Training Act of 2026
S.3888 is an early-stage, unfunded authorization bill. It creates no direct revenue stream for any public company. Market impact is negligible at this legislative stage.
Community Bank Relief Act
HR7484 (Community Bank Relief Act) is an early-stage procedural bill that indexes payment card transaction fee thresholds to inflation. It formalizes existing economic adjustments without altering current fee structures, regulatory obligations, or revenue for any payment processor. Market data shows mixed performance across the payment sector unrelated to this legislation. No immediate market impact.
Other Filings by David J. Taylor
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.